Giugliani, R., Boudes, P., Germain, D. P., Fernhoff, P., Nichols, K., Hughes, D., … Sitaraman, S. (2012). Evaluation of Globotriaosylceramide (GL-3) Accumulation in 18 Patients with Fabry Disease Nephropathy. Podocytes are More Severely Affected than Peritubular Capillaries. In Molecular Genetics and Metabolism (Vol. 105, pp. S31–S31). Elsevier BV. https://doi.org/10.1016/j.ymgme.2011.11.063

Giugliani, Roberto, Pol Boudes, Dominique P. Germain, Paul Fernhoff, Kathy Nichols, Derralynn Hughes, Atul Mehta, et al. “Evaluation of Globotriaosylceramide (GL-3) Accumulation in 18 Patients with Fabry Disease Nephropathy. Podocytes are More Severely Affected than Peritubular Capillaries.” In Molecular Genetics and Metabolism, 105:S31–S31. Elsevier BV, 2012. https://doi.org/10.1016/j.ymgme.2011.11.063.

Giugliani R, Boudes P, Germain DP, Fernhoff P, Nichols K, Hughes D, et al. Evaluation of Globotriaosylceramide (GL-3) Accumulation in 18 Patients with Fabry Disease Nephropathy. Podocytes are More Severely Affected than Peritubular Capillaries. In: Molecular Genetics and Metabolism. Elsevier BV; 2012. p. S31–S31.

Giugliani, Roberto, et al. “Evaluation of Globotriaosylceramide (GL-3) Accumulation in 18 Patients with Fabry Disease Nephropathy. Podocytes are More Severely Affected than Peritubular Capillaries.” Molecular Genetics and Metabolism, vol. 105, no. 2, Elsevier BV, 2012, pp. S31–S31. Crossref, doi:10.1016/j.ymgme.2011.11.063.

Giugliani R, Boudes P, Germain DP, Fernhoff P, Nichols K, Hughes D, Mehta A, Waldek S, Barisoni L, Jenette JC, Castelli J, Sitaraman S. Evaluation of Globotriaosylceramide (GL-3) Accumulation in 18 Patients with Fabry Disease Nephropathy. Podocytes are More Severely Affected than Peritubular Capillaries. Molecular Genetics and Metabolism. Elsevier BV; 2012. p. S31–S31.